Berlin, 17.01.2018 – Stellungnahme der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. zum Projekt S16-06 des IQWiG Nicht-invasive Pränataldiagnostik zur Bestimmung des Risikos autosomaler Trisomien 13,18 und 21 bei Risikoschwangerschaften

• Literatur

• 1 Gil MM, Accurti V, Santacruz B. et al. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2017; 35: 156
• 2 Mackie FL, Hemming K, Allen S. et al. The accuracy of cell‐free fetal DNA‐based non‐invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta‐analysis. BJOG 2017; 124: 32-46
• 3 Yaron Y. The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon. Prenat Diagn 2016; 36: 391-396
• 4 Norton ME, Jacobsson B, Swamy GK. et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015; 372: 1589-1597
• 5 Taylor-Phillips S, Freeman K, Geppert J. et al. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open 2016; 6: e010002
• 6 Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy. Obstet Gynecol 2015; 126: e31-e37
• 7 Salomon LJ, Alfirevic Z, Audibert F. et al. ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice. Ultrasound Obstet Gynecol 2017; 49: 815-816
• 8 Wapner RJ, Martin CL, Levy B. et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012; 367: 2175-2184
• 9 Schmid M, Klaritsch P, Arzt W. et al. Cell-Free DNA Testing for Fetal Chromosomal Anomalies in clinical practice: Austrian-German-Swiss Recommendations for non-invasive prenatal tests (NIPT). Ultraschall Med 2015; 36: 507-510